Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingye Zhang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Genetic Epidemiology|May 28, 2016
Detecting Gene-Environment Interactions for a Quantitative Trait in a Genome-Wide Association StudyPingye Zhang, Juan Pablo Lewinger, David Conti, et al.
Frontiers in Aging Neuroscience|June 14, 2021
Artificial Intelligence Can Effectively Predict Early Hematoma Expansion of Intracerebral Hemorrhage Analyzing Noncontrast Computed Tomography ImageLinyang Teng, Qianwei Ren, Pingye Zhang, et al.
Frontiers in Neurology|November 15, 2021
Automated Identification of Skull Fractures With Deep Learning: A Comparison Between Object Detection and Segmentation ApproachWei Shan, Jianwei Guo, Xuewei Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.
Lancet (London, England)|December 5, 2018
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E W Cohen, Denis Soulières, Christophe Le Tourneau, et al.
Dermatology and Therapy|September 24, 2021
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629Brett G M Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, et al.
The New England Journal of Medicine|August 18, 2021
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell CarcinomaToni K Choueiri, Piotr Tomczak, Se Hoon Park, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Genetic Epidemiology|May 28, 2016
Detecting Gene-Environment Interactions for a Quantitative Trait in a Genome-Wide Association StudyPingye Zhang, Juan Pablo Lewinger, David Conti, et al.
Frontiers in Aging Neuroscience|June 14, 2021
Artificial Intelligence Can Effectively Predict Early Hematoma Expansion of Intracerebral Hemorrhage Analyzing Noncontrast Computed Tomography ImageLinyang Teng, Qianwei Ren, Pingye Zhang, et al.
Frontiers in Neurology|November 15, 2021
Automated Identification of Skull Fractures With Deep Learning: A Comparison Between Object Detection and Segmentation ApproachWei Shan, Jianwei Guo, Xuewei Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.
Lancet (London, England)|December 5, 2018
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E W Cohen, Denis Soulières, Christophe Le Tourneau, et al.
Dermatology and Therapy|September 24, 2021
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629Brett G M Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, et al.
The New England Journal of Medicine|August 18, 2021
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell CarcinomaToni K Choueiri, Piotr Tomczak, Se Hoon Park, et al.
Pageof 2